Back

Sex differences in admission rates, use of anticoagulation, and outcomes for emergency department presentations of atrial fibrillation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 2 Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Patrick Daniele

University of British Columbia, Vancouver (Canada)

9 More presentations in this session

Presentation thumbnail
Stroke and bleeding in low, intermediate and high risk patients with atrial fibrillation treated with edoxaban: Results of the ETNA-AF Europe registry
Professor J. De Groot (Amsterdam, NL)
Abstract
Presentation thumbnail
Vitamin k antagonists are associated with higher risk of osteoporotic fractures compared to non-vitamin k antagonist oral anticoagulants among atrial fibrillation patients: a nationwide cohort study.
Doctor C. Binding (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study
Associate Professor H. Yu (Seoul, KR)
Abstract
Presentation thumbnail
Factors associated with inappropriate under-dosing of non-vitamin k antagonist oral anticoagulants (NOACs) by labelling criterion in patients with non-valvular atrial fibrillation in the UK
Doctor A. Ruigomez (Madrid, ES)
Abstract
Presentation thumbnail
New minimally invasive and tailor-made strategy for cryoballoon ablation in patients with paroxysmal atrial fibrillation
Doctor T. Nakano (Hiroshima, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 2

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources